...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Therapeutic advances in drug safety. >The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
【24h】

The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study

机译：用2秒停止（老年人的处方的筛选工具）对药物审查的影响并开始（筛选工具，以提醒医生在右治疗）中，在法国护理家庭中标准：3个月的后续研究

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Improving medication appropriateness is a priority of French national campaigns in nursing homes. A pilot study was conducted to evaluate the impact of a medication review in a French nursing home with a 3-month follow up. A medication review was conducted in 2015 using version 2 STOPP and START criteria. The number and type of drugs meeting a STOPP that were reintroduced and the number and type of drug meeting a START that were stopped during follow up were measured. An expert committee adjudicated whether 3-month hospitalizations and deaths were related to medication review. The impact of medication review on the cost related to drug consumption was calculated for 3?months. The 52 residents (age 84 ± 9?years, 83% female) fulfilled, on average, 2 ± 1.4 of the STOPP criteria and 0.7 ± 0.6 of the START criteria. A total of 101 drugs were stopped and 34 drugs were started. Five deaths occurred during follow up and were judged as not related to medication review. Five drugs stopped were reintroduced in five residents for a rebound effect or a symptom occurrence and one resident had stopped a START medication (aspirin) for a minor adverse drug reaction. At 3?months, a gain of 20.21 ± 31.34 euros per resident was observed. The medication review using version 2 STOPP and START criteria and involving the physician in charge seems useful for detecting and correcting inappropriate prescribing in a nursing home.
机译：提高药物适当是法国国家在护理家庭中的优先事项。进行了试点研究，以评估药物审查在法国养老院中的影响，3个月的跟进。使用版本2 STOPP并开始标准，在2015年进行了一种药物审查。衡量了已经重新引入的止动液的药物的数量和类型，并测量了在随访期间停止的起始的药物的数量和类型。专家委员会裁决3个月的住院和死亡是否与药物审查有关。药物治疗对与药物消费的成本的影响计算3？月份。 52名居民（84岁±9？岁月，83％的女性）平均满足STOPP标准的2±1​​.4，开始标准的0.7±0.6。共停止了101种药物，开始了34种药物。在随访期间发生了五次死亡，并被判断为与药物审查无关。已经在五个居民中重新引入了五种居民的五种居民，或者症状发生，一个居民已经停止了开始药物（阿司匹林）对次要的不良药物反应。在3个月，观察到每个居民的20.21±31.34欧元的收益。使用版本2停止和开始标准的药物审查以及涉及主人的医生似乎有助于检测和纠正在护理家中的不适当的处方。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号